Oruka Therapeutics (ORKA) earnings

Earnings (net income) · fiscal 2025
-$105.43M

Oruka Therapeutics (ORKA) reported net income of -$105.43M in fiscal 2025 (the year ended December 31, 2025). Figures as of 18 Nov 2026, 04:30 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
-$105.43M
Highest on record
-$511.00Kfiscal 2004
Lowest on record
-$105.43Mfiscal 2025
Fiscal years on record
212004–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Oruka Therapeutics earnings, in more detail

Across the 21 fiscal years on record (2004–2025), the highest was -$511.00K in fiscal 2004 and the lowest -$105.43M in fiscal 2025.

History · 21 fiscal years

Earnings (net income) by fiscal year

Oruka Therapeutics earnings, year by year

Oruka Therapeutics (ORKA) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025-$105.43M—
2023-$5.34M—
2022-$9.93M—
2021-$19.32M—
2020-$9.74M—
2019-$5.48M—
2018-$7.93M—
2017-$18.49M—
2016-$16.44M—
2015-$11.45M—
2014-$9.69M—
2013-$6.94M—
2012-$4.32M—
2011-$5.36M—
2010-$8.42M—
2009-$9.14M—
2008-$19.43M—
2007-$13.99M—
2006-$5.24M—
2005-$1.46M—
2004-$511.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Oruka Therapeutics and comparable companies
CompanyEarnings (net income)Fiscal year
Immunovant IMVT-$505.61M2026
Axsome Therapeutics AXSM-$183.17M2025
Chemed CHE$265.24M2025
Oruka Therapeutics ORKA-$105.43M2025
Arrowhead Pharmaceuticals ARWR-$724.21M2026

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ORKA

Oruka Therapeutics, figure by figure

Oruka Therapeutics (ORKA) overview: price, valuation and scorecardAll health care companies by market value

Oruka Therapeutics earnings: questions and answers

What is Oruka Therapeutics's net income?

Oruka Therapeutics (ORKA) reported net income of -$105.43M in fiscal 2025 (the year ended December 31, 2025).

What are the highest and lowest net income figures on record for Oruka Therapeutics?

Across the 21 fiscal years on record (2004–2025), the highest was -$511.00K in fiscal 2004 and the lowest -$105.43M in fiscal 2025.

How is Oruka Therapeutics's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Oruka Therapeutics (ORKA) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/ORKA/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.